Literature DB >> 2085676

Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid.

W G Dilley1, D E Haagensen, C E Cox, S A Wells.   

Abstract

A major protein of human breast cyst fluid, termed GCDFP-24, has the property of specifically binding progestins. The purified glycoprotein, of 24,000 apparent molecular weight, bound pregnenolone and progesterone with highest affinity. The association constant for binding of progesterone was 1 X 10(6)L/mol by Scatchard analysis, and there was one binding site per molecule. Changes to the progesterone structure at C-17, C-20, or C-21 interfered with binding. The pH optimum for binding was 4-4.5. The purified protein was highly stable and was not irreversibly denatured by 50% methanol or 3M guanidine. However, dithiothreitol reversibly interfered with progesterone binding. Rabbit antiserum produced against the glycoprotein recognized an immunologically identical component in normal human sera, and partially cross-reacting components in normal monkey and baboon sera. The component in human sera was present in Cohn fractions IV and VI.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085676     DOI: 10.1007/BF01806333

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Oestrogen-induced progesterone receptor in human uterus.

Authors:  O Jänne; K Kontula; T Luukkainen; R Vihko
Journal:  J Steroid Biochem       Date:  1975 Mar-Apr       Impact factor: 4.292

2.  Characterization and properties of progesterone-binding components in human endometrium.

Authors:  P C Young; R E Cleary
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

3.  Progesterone "receptor" in human endometrium.

Authors:  B R Rao; W G Wiest; W M Allen
Journal:  Endocrinology       Date:  1974-11       Impact factor: 4.736

4.  A specific progesterone-binding component of human breast cyst fluid.

Authors:  W H Pearlman; J L Guériguian; M E Sawyer
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

5.  Steroid hormone accumulation in human breast cyst fluid.

Authors:  H L Bradlow; R S Rosenfeld; J Kream; M Fleisher; J O'Connor; M K Schwartz
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

6.  A specific progesterone-binding component of human breast cyst fluid: its isolation and characterization [proceedings].

Authors:  W H Pearlman; L H Peng; G Mazoujian; D E Haagensen; S A Wells; S J Kister
Journal:  J Endocrinol       Date:  1977-12       Impact factor: 4.286

7.  Characteristics of progesterone-binding components in neoplastic mammary tissues of the rat.

Authors:  J E Goral; J L Wittliff
Journal:  Cancer Res       Date:  1976-06       Impact factor: 12.701

8.  Steroid-protein interaction with particular reference to testosterone binding by human serum.

Authors:  W H Pearlman; O Crépy
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

9.  Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients.

Authors:  D E Haagensen; G Mazoujian; W D Holder; S J Kister; S A Wells
Journal:  Ann Surg       Date:  1977-03       Impact factor: 12.969

10.  The binding of a synthetic progestin, R5020 to transcortin and serum albumin.

Authors:  D W Chan; W R Slaunwhite
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

View more
  13 in total

1.  Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.

Authors:  E A Thomas; B Dean; G Pavey; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  The neurobiology of apolipoproteins in psychiatric disorders.

Authors:  J Gregor Sutcliffe; Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

3.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

4.  A role of apolipoprotein D in triglyceride metabolism.

Authors:  German Perdomo; Dae Hyun Kim; Ting Zhang; Shen Qu; Elizabeth A Thomas; Frederico G S Toledo; Sandra Slusher; Yong Fan; David E Kelley; H Henry Dong
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

5.  Glucocorticoids and androgens up-regulate the Zn-alpha 2-glycoprotein messenger RNA in human breast cancer cells.

Authors:  Y S López-Boado; I Díez-Itza; J Tolivia; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Expression and prognostic significance of apolipoprotein D in breast cancer.

Authors:  I Díez-Itza; F Vizoso; A M Merino; L M Sánchez; J Tolivia; J Fernández; A Ruibal; C López-Otín
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

7.  Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease.

Authors:  Kosuke Tsukamoto; D R Mani; Jianru Shi; Songwen Zhang; Darrow E Haagensen; Fumiyuki Otsuka; Jian Guan; Jonathan D Smith; Wei Weng; Ronglih Liao; Frank D Kolodgie; Renu Virmani; Monty Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

8.  Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.

Authors:  D E Haagensen; P Stewart; W G Dilley; S A Wells
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Molecular dynamics analysis of apolipoprotein-D-lipid hydroperoxide interactions: mechanism for selective oxidation of Met-93.

Authors:  Aaron J Oakley; Surabhi Bhatia; Heath Ecroyd; Brett Garner
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

10.  Modulation of Apolipoprotein D levels in human pregnancy and association with gestational weight gain.

Authors:  Sonia Do Carmo; Jean-Claude Forest; Yves Giguère; André Masse; Julie Lafond; Eric Rassart
Journal:  Reprod Biol Endocrinol       Date:  2009-09-02       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.